Please login to the form below

Not currently logged in

Euro'vision blog

A look at the key issues for pharma across Europe

Max Jackson Standing on the shoulders of giants

29 Nov 2011

Has a world where we are ring fenced by financial and legal scrutiny brought us to a safe area where over-cautiousness prevails? Max Jackson reflects on those who contribute a

  • Max Jackson AMNOG – trick or treat?

    10 Nov 2011

    It’s referred to as the “reorganisation of the pharma market”. What exactly are the implications of the German AMNOG legislation, adopted by Bundestag (the national parliament), and will other countries

  • Max Jackson Is there a doctor in the house?

    27 Oct 2011

    We hear much talk about the future of pharma being focused on producing more innovative medicines and reaching new markets. But the key players in the industry within Europe have

  • Max Jackson Pharmaceutical marketing in Europe – should we call a priest?

    05 Oct 2011

    What’s the talk in Europe? Catch up with new regulation in Spain and France, and a shelved product launch in Germany

1 2 3


COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...